http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010540953-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-067 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2400-12 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5308 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57438 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-66 |
| filingDate | 2008-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2010-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2010540953-A |
| titleOfInvention | Glycosylation markers for pancreatitis, sepsis and pancreatic cancer |
| abstract | The present invention provides novel biomarkers for use in the diagnosis and prognosis of cancer and chronic inflammation, as well as the diagnosis and prognosis of diseases mediated by chronic inflammation. The biomarker is a glycoprotein, and its level has been correlated by the inventor to correspond to a specific disease state. The invention further extends to methods for monitoring the response to therapy of treatment of cancer or chronic inflammatory conditions. [Selection] Figure 5 |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014134435-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022024995-A1 |
| priorityDate | 2007-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 597.